Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds OTR Global Downgrades Generac Hldgs to Negative

OTR Global Downgrades Generac Hldgs to Negative

OTR Global downgrades Generac Hldgs (NYSE:GNRC) from Mixed to Negative.

byBenzinga Newsdesk

July 22, 2022

1 minute read

OTR Global downgrades Generac Hldgs (NYSE:GNRC) from Mixed to Negative.

Guggenheim Maintains Buy on Aptiv, Raises Price Target to $152

By Benzinga Newsdesk

February 15, 10:03 AM

Guggenheim analyst Ronald Jewsikow maintains Aptiv (NYSE:APTV) with a Buy and raises the price target from $138 to $152.

APTV

Analyst Ratings

5 Analysts Have This to Say About Shift4 Payments

By Benzinga Insights

January 20, 2:00 PM

Analysts have provided the following ratings for Shift4 Payments (NYSE:FOUR) within the last quarter: Bullish Somewhat Bullish Indifferent…

FOUR

Analyst Ratings

Morgan Stanley Maintains Equal-Weight Rating for Shutterstock: Here’s What You Need To Know

By Benzinga Insights

November 1, 1:00 PM

Morgan Stanley has decided to maintain its Equal-Weight rating of Shutterstock (NYSE:SSTK) and lower its price target from…

SSTK

Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical

By Vandana Singh

February 14, 8:59 AM

Fusion Pharmaceuticals Inc (NASDAQ:FUSN) acquired the investigational new drug application for an ongoing Phase 2 TATCIST trial evaluating 225Ac-PSMA…

FUSN

OTR Global Downgrades Generac Hldgs to Negative

Related Posts

Guggenheim Maintains Buy on Aptiv, Raises Price Target to $152

5 Analysts Have This to Say About Shift4 Payments

Morgan Stanley Maintains Equal-Weight Rating for Shutterstock: Here’s What You Need To Know

Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical